Video Experimental Relacionado
Updated: Feb 6, 2026
05:56
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
580
Secuenciación del exoma completo ilumina la enfermedad hepática colestásica pediátrica inexplicada
1Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States. toshifumi.yodoshi@cchmc.org.
World journal of hepatology
|February 5, 2026
Resumen
La secuenciación del exoma completo (WES) mejora significativamente el diagnóstico de enfermedades hepáticas genéticas raras en niños. Este enfoque de prueba genética ayuda a una identificación oportuna y precisa, guiando un mejor tratamiento y resultados para las afecciones hepáticas pediátricas.
Área de la Ciencia:
- Hepatología Pediátrica
- Genética
- Genómica
Sus antecedentes:
- La enfermedad hepática inexplicable en niños presenta desafíos diagnósticos.
- Las enfermedades hepáticas pediátricas no infecciosas se están expandiendo.
- Un diagnóstico preciso es crucial para la atención óptima y la asignación de recursos.
Objetivo del estudio:
- Sintetizar la evidencia sobre el impacto de las pruebas genéticas en la hepatología pediátrica.
- Destacar el papel de la secuenciación del exoma completo (WES) en el diagnóstico de enfermedades hepáticas.
- Discutir la integración de la genómica con los diagnósticos convencionales.
Principales métodos:
- Revisión de informes internacionales sobre el rendimiento de las pruebas genéticas.
- Comparación de WES y paneles de genes amplios en enfermedades hepáticas pediátricas.
- Síntesis de evidencia sobre mejoras diagnósticas.
Principales resultados:
- Las pruebas genéticas integrales, en particular la WES, aumentan sustancialmente el rendimiento diagnóstico.
- La WES es eficaz en lactantes con colestasis y en niños con aminotransferasa elevada.
- Las pruebas genéticas descubren diversas causas genéticas de enfermedades hepáticas pediátricas en diferentes regiones.
Conclusiones:
- La WES es una herramienta poderosa para diagnosticar enfermedades hepáticas pediátricas inexplicables.
- La integración de WES con la evaluación clínica y otras investigaciones es esencial.
- Los enfoques genómicos avanzan la medicina personalizada y mejoran los resultados en la hepatología pediátrica.
Videos de Conceptos Relacionados
01:26Diseases of the Liver and Gallbladder
2.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
202
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
202
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
02:02Cis-regulatory Sequences
11.8K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.8K
01:29Sequences
278
Sequences are fundamental mathematical objects consisting of ordered lists of numbers that follow a specific rule or pattern. Sequences are critical in various mathematical concepts, including calculus, series, and number theory. They can model real-world phenomena such as population growth, financial investments, and physical processes like the diminishing height of a bouncing ball.Each number in a sequence is referred to as a term. Typically, the terms are denoted as a1, a2, a3,…, where...
278
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
314
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314